Scott M. Fishman, MD
Chief, Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis; Associate Professor of Anesthesiology, University of California, Davis; Director at large, American Academy of Pain Medicine

David Teichera, MD
Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis; Assistant Professor of Anesthesiology, University of California, Davis

Address: Scott M. Fishman, MD, Chief, Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis, Ellison Ambulatory Care Bldg, Suite 3200, 4860 Y Street, Sacramento, CA 95817; e-mail: [email protected]

Scott M. Fishman, MD
Chief, Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis; Associate Professor of Anesthesiology, University of California, Davis; Director at large, American Academy of Pain Medicine

David Teichera, MD
Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis; Assistant Professor of Anesthesiology, University of California, Davis

Address: Scott M. Fishman, MD, Chief, Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis, Ellison Ambulatory Care Bldg, Suite 3200, 4860 Y Street, Sacramento, CA 95817; e-mail: [email protected]

Scott M. Fishman, MD
Chief, Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis; Associate Professor of Anesthesiology, University of California, Davis; Director at large, American Academy of Pain Medicine

David Teichera, MD
Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis; Assistant Professor of Anesthesiology, University of California, Davis

Address: Scott M. Fishman, MD, Chief, Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of California, Davis, Ellison Ambulatory Care Bldg, Suite 3200, 4860 Y Street, Sacramento, CA 95817; e-mail: [email protected]

Christopher M. Bono, MD
Department of Orthopaedic Surgery, Boston Medical Center

Address: Christopher M. Bono, MD, Department of Orthopaedic Surgery, Boston Medical Center, 850 Harrison Avenue, Dowline 2 North, Boston, MA 02118; email: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Christopher M. Bono, MD
Department of Orthopaedic Surgery, Boston Medical Center

Address: Christopher M. Bono, MD, Department of Orthopaedic Surgery, Boston Medical Center, 850 Harrison Avenue, Dowline 2 North, Boston, MA 02118; email: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Christopher M. Bono, MD
Department of Orthopaedic Surgery, Boston Medical Center

Address: Christopher M. Bono, MD, Department of Orthopaedic Surgery, Boston Medical Center, 850 Harrison Avenue, Dowline 2 North, Boston, MA 02118; email: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator, Research Studies, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Alex Mompoint, MD
Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Amarish Potnis, MD
Telemark Physical Medicine, Greenville, PA

Address: Daniel J. Mazanec, MD, Director, Spine Center, Rheumatologic & Immunologic Disease, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator, Research Studies, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Alex Mompoint, MD
Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Amarish Potnis, MD
Telemark Physical Medicine, Greenville, PA

Address: Daniel J. Mazanec, MD, Director, Spine Center, Rheumatologic & Immunologic Disease, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator, Research Studies, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Alex Mompoint, MD
Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Amarish Potnis, MD
Telemark Physical Medicine, Greenville, PA

Address: Daniel J. Mazanec, MD, Director, Spine Center, Rheumatologic & Immunologic Disease, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Steven M. Gordon, MD
Hospital Epidemiologist, Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S31, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Steven M. Gordon, MD
Hospital Epidemiologist, Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S31, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Steven M. Gordon, MD
Hospital Epidemiologist, Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S31, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Practice Recommendations from Key Studies

Vetrhus M, Søreide O, Solhaug JH, et al. Symptomatic, non-complicated gallbladder stone disease. Operation or observation? Scand J Gastroenterol 2002; 37:834–9.

Norman M. Oliver, MD
Department of Family Medicine, University of Virginia Health Systems, Charlottesville.

[email protected].

Practice Recommendations from Key Studies

Vetrhus M, Søreide O, Solhaug JH, et al. Symptomatic, non-complicated gallbladder stone disease. Operation or observation? Scand J Gastroenterol 2002; 37:834–9.

Norman M. Oliver, MD
Department of Family Medicine, University of Virginia Health Systems, Charlottesville.

[email protected].

Practice Recommendations from Key Studies

Vetrhus M, Søreide O, Solhaug JH, et al. Symptomatic, non-complicated gallbladder stone disease. Operation or observation? Scand J Gastroenterol 2002; 37:834–9.

Norman M. Oliver, MD
Department of Family Medicine, University of Virginia Health Systems, Charlottesville.

[email protected].

Practice Recommendations from Key Studies

Callahan CM, Unverzagt FW, Hui SL, et al. Six-item screener to identify cognitive impairment among potential subject for clinical research. Med Care 2002; 40:771–81.

Michael Klein, MD
Warren Newton, MD, MPH
Department of Family Medicine, University of North Carolina, Chapel Hill.

[email protected].

Practice Recommendations from Key Studies

Callahan CM, Unverzagt FW, Hui SL, et al. Six-item screener to identify cognitive impairment among potential subject for clinical research. Med Care 2002; 40:771–81.

Michael Klein, MD
Warren Newton, MD, MPH
Department of Family Medicine, University of North Carolina, Chapel Hill.

[email protected].

Practice Recommendations from Key Studies

Callahan CM, Unverzagt FW, Hui SL, et al. Six-item screener to identify cognitive impairment among potential subject for clinical research. Med Care 2002; 40:771–81.

Michael Klein, MD
Warren Newton, MD, MPH
Department of Family Medicine, University of North Carolina, Chapel Hill.

[email protected].

Lisa K. Mannix, MD
Headache Specialist, Cincinnati, OH

Address: Lisa K. Mannix, MD, 4760 E. Galbraith Road, Suite 206, Cincinnati, OH 45236; e-mail: [email protected]

The author has indicated that she has received grant or research support from the AstraZeneca, GlaxoSmithKline, Ortho-McNeil, and Pharmacia corporations, serves as a consultant to the Abbott Laboratories, AstraZeneca, Elan Pharmaceuticals, GlaxoSmithKline, Merck & Co., Ortho-McNeil, Pfizer, and Pharmacia corporations, and is on the speakers’ bureaus of the Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Merck & Co., and Pfizer corporations.

Lisa K. Mannix, MD
Headache Specialist, Cincinnati, OH

Address: Lisa K. Mannix, MD, 4760 E. Galbraith Road, Suite 206, Cincinnati, OH 45236; e-mail: [email protected]

The author has indicated that she has received grant or research support from the AstraZeneca, GlaxoSmithKline, Ortho-McNeil, and Pharmacia corporations, serves as a consultant to the Abbott Laboratories, AstraZeneca, Elan Pharmaceuticals, GlaxoSmithKline, Merck & Co., Ortho-McNeil, Pfizer, and Pharmacia corporations, and is on the speakers’ bureaus of the Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Merck & Co., and Pfizer corporations.

Lisa K. Mannix, MD
Headache Specialist, Cincinnati, OH

Address: Lisa K. Mannix, MD, 4760 E. Galbraith Road, Suite 206, Cincinnati, OH 45236; e-mail: [email protected]

The author has indicated that she has received grant or research support from the AstraZeneca, GlaxoSmithKline, Ortho-McNeil, and Pharmacia corporations, serves as a consultant to the Abbott Laboratories, AstraZeneca, Elan Pharmaceuticals, GlaxoSmithKline, Merck & Co., Ortho-McNeil, Pfizer, and Pharmacia corporations, and is on the speakers’ bureaus of the Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Merck & Co., and Pfizer corporations.

Wesson KM, Silverberg NB

Wesson KM, Silverberg NB

Wesson KM, Silverberg NB